2013 IPO

Savara

$2.54
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.09 (-3.41%) As of 3:12 PM EDT today
-$0.09 (-3.41%) Today

Why Robinhood?

You can buy or sell Savara and other stocks, options, ETFs, and crypto commission-free!

About SVRA

Savara Inc. Common Stock, also called Savara, is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Read More Its products include AeroVanc, Molgradex, GM-CSF, and Aironite. The company was founded on April 27, 2017 and is headquartered in Austin, TX.

Employees
33
Headquarters
Austin, Texas
Founded
2017
Market Cap
94.23M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
307.20K
High Today
$2.63
Low Today
$2.53
Open Price
$2.62
Volume
185.28K
52 Week High
$13.25
52 Week Low
$2.32

Collections

2013 IPO

SVRA News

Washington PostJun 13

Red Robin, Schlumberger and Lennar rise while Savara plunges

236

SVRA Earnings

-$0.88
-$0.66
-$0.45
-$0.23
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, After Hours

More SVRA News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.